Literature DB >> 1521730

Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects.

P M Clark1, J C Levy, L Cox, M Burnett, R C Turner, C N Hales.   

Abstract

Plasma insulin, intact proinsulin and 32-33 split proinsulin measured by specific immunoradiometric assays and insulin and C-peptide measured by radioimmunoassay were measured during a constant infusion of glucose test in ten diet-treated subjects with a history of Type 2 (non-insulin-dependent) diabetes (termed diabetic subjects), mean fasting plasma glucose 6.0 +/- 1.0 mmol/l (mean +/- SD), and 12 non-diabetic control subjects. Immunoreactive insulin concentrations measured by radioimmunoassay were 33% higher than insulin and 16% higher than the sum of insulin and its precursors by immunoradiometric assay. The diabetic and non-diabetic subjects had similar fasting concentrations of insulin, intact proinsulin and 32-33 split proinsulin. The ratio of fasting intact proinsulin to total insulin was greater in the diabetic than the non-diabetic group 12.0% (6.8-21.0%, 1 SD range) and 6.3% (4.0-9.8%), respectively, p less than 0.01), though the groups overlapped substantially. After glucose infusion, diabetic and non-diabetic subjects had similar intact proinsulin concentrations (geometric mean 4.9 and 5.2 pmol/l, respectively), but the diabetic group had impaired insulin secretion by immunoradiometric assay (geometric means 55 and 101 pmol/l, p less than 0.05) or by radioimmunoassay C-peptide (geometric means 935 and 1410 pmol/l, p less than 0.05), though not by radioimmunoassay insulin (87 and 144 pmol/l, p = 0.12), respectively. Individual immunoradiometric assay insulin responses to glucose expressed in terms of obesity were subnormal in nine of ten diabetic subjects. Radioimmunoassay insulin and C-peptide gave less complete discrimination (subnormal responses in six of ten and eight of ten, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1521730     DOI: 10.1007/bf02342446

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  22 in total

1.  CRITICAL FACTORS IN EXCESSIVE SERUM-INSULIN RESPONSE TO GLUCOSE. OBESITY IN MATURITY-ONSET DIABETES AND GROWTH HORMONE IN ACROMEGALY.

Authors:  J H KARAM; G M GRODSKY; F C PAVLATOS; P H FORSHAM
Journal:  Lancet       Date:  1965-02-06       Impact factor: 79.321

2.  A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties.

Authors:  J D Albano; R P Ekins; G Maritz; R C Turner
Journal:  Acta Endocrinol (Copenh)       Date:  1972-07

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics.

Authors:  R C Temple; P M Clark; D K Nagi; A E Schneider; J S Yudkin; C N Hales
Journal:  Clin Endocrinol (Oxf)       Date:  1990-06       Impact factor: 3.478

5.  Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins.

Authors:  W J Sobey; S F Beer; C A Carrington; P M Clark; B H Frank; I P Gray; S D Luzio; D R Owens; A E Schneider; K Siddle
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

6.  Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels.

Authors:  W C Duckworth; S S Solomon; A E Kitabchi
Journal:  J Clin Endocrinol Metab       Date:  1972-10       Impact factor: 5.958

7.  Circulating proinsulin in patients with maturity onset diabetes.

Authors:  M E Mako; J I Starr; A H Rubenstein
Journal:  Am J Med       Date:  1977-12       Impact factor: 4.965

8.  Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.

Authors:  L Rossetti; G I Shulman; W Zawalich; R A DeFronzo
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

9.  Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release.

Authors:  S Bonner-Weir; D F Trent; G C Weir
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

10.  Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.

Authors:  J C Levy; A Rudenski; M Burnett; R Knight; D R Matthews; R C Turner
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122

View more
  6 in total

1.  Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects.

Authors:  L Mykkänen; S M Haffner; J Kuusisto; K Pyörälä; C N Hales; M Laakso
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

2.  Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study.

Authors:  G Nijpels; C Popp-Snijders; P J Kostense; L M Bouter; R J Heine
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

3.  Infant nutrition and subsequent risk of type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  G K Dowse; P Z Zimmet; K G Alberti
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

4.  A sensitive and reliable method for assaying true human insulin without interaction with human proinsulin-like molecules.

Authors:  L D Monti; E P Sandoli; V C Phan; P M Piatti; S Costa; A Secchi; G Pozza
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

Review 5.  Altered β-Cell Prohormone Processing and Secretion in Type 1 Diabetes.

Authors:  Teresa Rodriguez-Calvo; Yi-Chun Chen; C Bruce Verchere; Leena Haataja; Peter Arvan; Pia Leete; Sarah J Richardson; Noel G Morgan; Wei-Jun Qian; Alberto Pugliese; Mark Atkinson; Carmella Evans-Molina; Emily K Sims
Journal:  Diabetes       Date:  2021-05-04       Impact factor: 9.337

6.  The Human and Mouse Islet Peptidome: Effects of Obesity and Type 2 Diabetes, and Assessment of Intraislet Production of Glucagon-like Peptide-1.

Authors:  Sam G Galvin; Richard G Kay; Rachel Foreman; Pierre Larraufie; Claire L Meek; Emma Biggs; Peter Ravn; Lutz Jermutus; Frank Reimann; Fiona M Gribble
Journal:  J Proteome Res       Date:  2021-08-23       Impact factor: 4.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.